Cargando…
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein
Influenza virus infection is a prevalent disease in humans. Antibodies against hemagglutinin have been shown to prevent infection and hence hemagglutinin is the major constituent of current vaccines. Antibodies directed against the highly conserved extracellular domain of M2 have also been shown to...
Autores principales: | Beerli, Roger R, Bauer, Monika, Schmitz, Nicole, Buser, Regula B, Gwerder, Myriam, Muntwiler, Simone, Renner, Wolfgang A, Saudan, Philippe, Bachmann, Martin F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804611/ https://www.ncbi.nlm.nih.gov/pubmed/20025741 http://dx.doi.org/10.1186/1743-422X-6-224 |
Ejemplares similares
-
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
por: Schmitz, Nicole, et al.
Publicado: (2009) -
New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
por: Friesen, Robert H. E., et al.
Publicado: (2010) -
Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles
por: Jegerlehner, Andrea, et al.
Publicado: (2013) -
Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza
por: Simmons, Cameron P, et al.
Publicado: (2007) -
Monoclonal antibodies for prophylactic and therapeutic use against viral infections
por: Both, Leonard, et al.
Publicado: (2013)